Loading clinical trials...
Loading clinical trials...
An Open-label, Randomized, Parallel-group Study to Assess the Pharmacokinetic Bioequivalence of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants
Conditions
Interventions
Guselkumab
Locations
2
United States
Celerion
Tempe, Arizona, United States
CRS Clinical Research Services
Mannheim, Germany
Start Date
October 30, 2019
Primary Completion Date
September 13, 2021
Completion Date
December 7, 2021
Last Updated
February 3, 2025
NCT06290258
NCT00090662
NCT06716502
NCT07310264
NCT07483606
NCT07310901
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions